Clinical Trials Browser

INDUSTRY × Panobinostat × Lymphoid × Clear all

NCT00490776 2021-08-18

Study of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL)

Phase 2 Terminated

9 enrolled 6 charts

DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT00742027 2021-07-28

Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma

Phase 2 Completed

129 enrolled 16 charts

Hodgkin Disease

NCT00503451 2020-12-19

A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors

Phase 1 Completed

Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms

NCT01034163 2016-07-07

PATH

Phase 3 Completed

41 enrolled 7 charts

Hodgkin Disease

NCT00412997 2012-11-27

LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma

Phase 1 Completed

DermatologicLymphoid

Neoplasms, Lymphoma, T-Cell, Cutaneous

NCT00699296 2012-11-27

Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma

Phase 2 Terminated

DermatologicLymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Cutaneous

NCT00472368 2012-05-01

A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589

Phase 1 Completed

Lymphoma